PLX3397, a CSF1 receptor inhibitor, limits allotransplantation-induced vascular remodelling is a research paper published in Cardiovascular Research (2021). On theSindex it has a DataRank of 0.572. It has been cited 9 times, with 7 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.345
From this paper's citation signal
Citation Network Contribution
0.227
From 6 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 7 citers.
National Institute of Health Predoctoral Individual National Research Service Award
Grant: NIH F31HL144041
Training Program in Cellular and Molecular Biology and Genetics
Grant: T32 GM007491
American Heart Association
Grant: 19CDA34660217
National Institute of Health
Grant: R01128066
National Institute of Health
Grant: R01HL133861
NHLBI NIH HHS
Grant: F31 HL144041
NHLBI NIH HHS
Grant: R01 HL128066
FWCI
0.52
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals